Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Rheumatology|May 17, 2024
Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL datasetSabina Ciciriello, Geoffrey O Littlejohn, Tamas Treuer, et al.
Plos Computational Biology|March 7, 2025
Penalised regression improves imputation of cell-type specific expression using RNA-seq data from mixed cell populations compared to domain-specific methodsWei-Yu Lin, Melissa Kartawinata, Bethany R Jebson, et al.
Frontiers in Digital Health|January 26, 2023
A novel electronic patient-reported outcome delivery system to implement health-related quality of life measures in routine clinical care: An analysis of 5 years of experienceKathleen Tymms, Catherine O'Sullivan, Tegan Smith, et al.
Frontiers in Immunology|February 2, 2019
Sex and Pubertal Differences in the Type 1 Interferon Pathway Associate With Both X Chromosome Number and Serum Sex Hormone ConcentrationKate Webb, Hannah Peckham, Anna Radziszewska, et al.
Annals of the Rheumatic Diseases|July 18, 2025
Identification and validation of interferon-driven gene signature as a predictor of response to methotrexate in juvenile idiopathic arthritisMelissa Kartawinata, Wei-Yu Lin, Beth Jebson, et al.
Rheumatology (Oxford, England)|November 4, 2020
Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture modelsClaire T Deakin, Charalampia Papadopoulou, Liza J McCann, et al.
JAMA Network Open|June 29, 2023
Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in AustraliaClaire T Deakin, Bianca L De Stavola, Geoffrey Littlejohn, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 24, 2016
Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile DermatomyositisClaire T Deakin, Shireena A Yasin, Stefania Simou, et al.
Diabetes Research and Clinical Practice|May 10, 2025
Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based studyJialing Lin, Tamara Y Milder, Claire T Deakin, et al.
Clinical and Experimental Immunology|December 25, 2024
Type I interferon and mitochondrial dysfunction are associated with dysregulated cytotoxic CD8+ T cell responses in juvenile systemic lupus erythematosusAnna Radziszewska, Hannah Peckham, Restuadi Restuadi, et al.
Pageof 4